Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T02:05:36.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk

Published online by Cambridge University Press:  05 January 2009

Atsushi Hayashi ,
Makoto Kimura ,
Yusaku Nakamura  and
Hisako Yasui
Atsushi Hayashi
Affiliation:
Science of Functional Foods Graduate School of Agriculture, Shinshu University, 8304 Minamiminowa, Kamiina, Nagano 399-4598, Japan
Makoto Kimura
Affiliation:
Science of Functional Foods Graduate School of Agriculture, Shinshu University, 8304 Minamiminowa, Kamiina, Nagano 399-4598, Japan
Yusaku Nakamura
Affiliation:
Science of Functional Foods Graduate School of Agriculture, Shinshu University, 8304 Minamiminowa, Kamiina, Nagano 399-4598, Japan
Hisako Yasui*
Affiliation:
Science of Functional Foods Graduate School of Agriculture, Shinshu University, 8304 Minamiminowa, Kamiina, Nagano 399-4598, Japan
*
*For correspondence; e-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We investigated the anti-allergic effects of one strain (T120) of a lactic acid bacteria (LAB) isolated from Mongolian fermented milk using atopic dermatitis (AD) model mice (NC/Nga mice). Strain T120 has already been identified as Enterococcus faecium and shown to induce strong production of IL-12 (Kimura et al. 2006). In in vitro studies, strain T120 suppressed total IgE production and induced IL-12 and IFN-γ production by splenocytes of NC/Nga mice. The additional examination of various neutralization antibodies was performed to elucidate in detail the mechanism of depressed IgE production by strain T120. As a result, it became clear that IL-12 induced by strain T120 increased production of IFN-γ and total IgE production was mainly controlled by the IFN-γ. In order to define the cells which produce IL-12 powerfully by this strain, antigen-presenting cells (APCs) such as macrophages and dendritic cells (DCs) were removed from the splenocytes, and the reactivity of these cells to the strain was examined. Induction of IL-12 and IFN-γ by strain T120 became significantly very low by removal of APCs from splenocytes. Therefore, it was clear that strain T120 acted on APCs and induced production of IL-12. Further, this strain enhanced the production of IL-10 by splenocytes. In in vivo studies, intraperitoneal injection of strain T120 inhibited serum IgE elevation and atopic dermatitis symptoms in NC/Nga mice. These results suggest that an anti-allergic effect of strain T120 depends on the increased production of IL-12 by APCs activated by the strain and following the increased production of IFN-γ. Further, activation of regulatory T cells by strain T120 may inhibit atopic desease.

Keywords

NC/Nga mouseatopic dermatitislactic acid bacteriaanti-allergy
Type
Research Article
Information
Journal of Dairy Research , Volume 76 , Issue 2 , May 2009 , pp. 158 - 164
Copyright
Copyright © Proprietors of Journal of Dairy Research 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbas, AK, Muphy, M & Sher, A 1996 Functional diversity of helper T lymphocytes. Nature 383 787–793Google Scholar
Chen, Y, Kuchroo, VK, Inobe, J, Hafler, DA & Weiner, HL 1994 Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 1237–1240Google Scholar
Groux, H, O'Garra, A, Bigler, M, Rouleau, M, Antonenko, S, De Vries, JE & Roncarolo, MG 1997 A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 386 737–742CrossRefGoogle Scholar
Fujiwara, D, Inoue, S, Wakabayashi, H & Fujii, T 2004 The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. International Archives of Allergy and Immunology 135 205–215Google Scholar
Hanifin, JM & Rajka, G 1980 Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica 92 44–47Google Scholar
Ishida, Y, Bandou, I, Kanzato, H & Yamamoto, N 2003 Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Bioscience, Biotechnology and Biochemistry 67 951–957CrossRefGoogle ScholarPubMed
Isolauri, E, Arvola, T, Sutas, Y, Moilanen, E & Salminen, S 2000 Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 30 1604–1610Google Scholar
Kalliomaki, M, Salminen, S, Arvilommi, H, Kero, P, Koskinen, P & Isolauri, E 2001 Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 1076–1079Google Scholar
Kimura, M, Danno, K & Yasui, H 2006 Immunomodulatory function and probiotic properties of lactic acid bacteria isolated form Mongolian fermented milk. Bioscience and Microflora 25 147–155CrossRefGoogle Scholar
Kondo, K, Nagami, T & Teramoto, S 1969 Differernces in haematopoietic death among inbred strains of mice. In Comparative Cellular and Species Radiosensitivity, pp. 20 (Eds Bond, PV & Sugahara, T). Japan: IgakushoinGoogle Scholar
Levings, MK & Roncarolo, MG 2000 T-regulatory 1 cells: a novel subset of CD+ T cells with immunoregulatory properties. The Journal of Allergy and Clinical Immunology 106 109–112Google Scholar
Leung, D, Hirsch, R, Schneider, L, Moody, C, Takaoka, R, Li, S, Meyerson, L, Mariam, S, Goldstein, G & Hanifin, J 1990 Thymopentin therapy reduces the clinical severity of atopic dermatitis. Journal of Allergy and Clinical Immunology 85 927–933CrossRefGoogle ScholarPubMed
Matsuda, H, Watanabe, N, Geba, GP, Sperl, J, Tsudzuki, M, Hiroi, J, Matsumoto, M, Ushio, H, Saito, S, Askenase, PW & Ra, C 1997 Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. International Immunology 9 461–466CrossRefGoogle ScholarPubMed
Matsuzaki, T, Yamazaki, S, Hashimoto, S & Yokokura, T 1998 The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. Journal of Dairy Science 81 48–53CrossRefGoogle ScholarPubMed
Mosmann, TR, Cherwinski, H, Bond, MW, Giedlin, MA & Coffman, RL 1986 Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136 2348–2357Google Scholar
Okamoto, A, Kawamura, T, Kanbe, K, Kanamaru, Y, Ogawa, H, Okumura, K & Nakao, A 2005 Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-beta. International Immunology 17 705–712Google Scholar
Pessi, T, Sutas, Y, Hurme, M & Isolauri, E 2000 Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clinical and Experinental Allergy 30 1804–1808CrossRefGoogle ScholarPubMed
Platts-Mills, TA 2001 The role of immunoglobulin E in allergy and asthma. American Journal of Respiratory and clinical care medicine 164 1–5CrossRefGoogle ScholarPubMed
Powrie, F & Coffman, RL 1993 Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunology Today 14 270–274Google Scholar
Rautava, S, Kalliomaki, M & Isolauri, E 2002 Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. The Journal of Allergy and Clinical Immunology 109 119–121Google Scholar
Shida, K, Takahashi, R, Iwadate, E, kamizawa, K, Yasui, H, Sato, T, Habu, S, Hachimura, S & Kaminogawa, S 2002 Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clinical and Experinental Allergy 32 563–570CrossRefGoogle Scholar
Shida, K, Makino, K, Morishita, A, Takamizawa, K, Hachimura, S, Ametani, A, Sato, T, Kumagai, Y, Habu, S & Kaminogawa, S 1998 Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. International Archives of Allergy and Immunology 115 278–287Google Scholar
Weiner, HL 1997 Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunology Today 18 335–343CrossRefGoogle ScholarPubMed
Yagi, R, Nagai, H, Iigo, Y, Arai, T & Kudo, K 2002 Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. Journal of Immunology 168 2020–2027CrossRefGoogle ScholarPubMed
Yasui, H, Shida, K, Matsuzaki, T & Yokokura, T 1999 Immunomodulatory function of lactic acid bacteria. Antonie van Leeuwenhoek 76 383–389CrossRefGoogle ScholarPubMed
Yasui, H, Mike, A & Ohwaki, M 1989 Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration. Journal of Dairy Science 72 30–35CrossRefGoogle ScholarPubMed